The cyanobacterial oligopeptides microginins induce DNA damage in the human hepatocellular carcinoma (HepG2) cell

Andrea Zsuzsanna Ujvárosi1, Klara Hercog2, Milán Riba1

  • 1Department of Botany, Institute of Biology and Ecology, Faculty of Science and Technology, University of Debrecen, Hungary.

Chemosphere
|September 23, 2019
PubMed

Insights

This study reveals that microginins (MGs), compounds from cyanobacteria, cause DNA damage and genomic instability in human liver cancer cells. This is the first evidence of microginins

Area of Science:

  • Environmental toxicology
  • Cyanobacterial metabolite research
  • Hepatocellular carcinoma studies

Background:

  • Microginins (MGs) are bioactive compounds produced by Microcystis spp. (Cyanobacteria).
  • These cyanobacteria are prevalent in eutrophic aquatic environments.
  • Understanding the toxicological profile of MGs is crucial due to their environmental presence.

Purpose of the Study:

  • To evaluate the cytotoxic and genotoxic effects of four microginin congeners and a cyanobacterial extract.
  • To assess the impact on human hepatocellular carcinoma (HepG2) cells.
  • To provide the first evidence of microginins exerting genotoxic activity.

Main Methods:

  • Cytotoxicity assessed using the MTT assay.
  • Genotoxicity evaluated via comet, γH2AX, and cytokinesis-block micronucleus (CBMN) assays.
  • Exposure of HepG2 cells to microginins (MG FR3, MG GH787, cyanostatin B, MGL 402) and cyanobacterial extract B-14-01.

Main Results:

  • Microginins and the extract reduced cell proliferation after 72h, with MGL 402 being most potent and MG FR3 least potent.
  • All tested compounds induced DNA strand breaks; the extract was most potent, followed by MGL 402.
  • Genomic instability was observed with MG GH787, cyanostatin B, and the extract, but no DNA double-strand breaks were detected.

Conclusions:

  • This study provides the first evidence that microginins possess genotoxic activity.
  • Microginins can induce DNA strand breaks and genomic instability in human liver cancer cells.
  • The findings highlight the potential health risks associated with microginin exposure.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.0K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.9K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
43.2K